SE386168B - Nya kinazolinderivat till anvendning som mellanprodukter for framstellning av terapeutisk verdefulla bensoiazepinderivat - Google Patents

Nya kinazolinderivat till anvendning som mellanprodukter for framstellning av terapeutisk verdefulla bensoiazepinderivat

Info

Publication number
SE386168B
SE386168B SE7008427A SE842770A SE386168B SE 386168 B SE386168 B SE 386168B SE 7008427 A SE7008427 A SE 7008427A SE 842770 A SE842770 A SE 842770A SE 386168 B SE386168 B SE 386168B
Authority
SE
Sweden
Prior art keywords
benzoiaze
individuals
new
production
intermediate products
Prior art date
Application number
SE7008427A
Other languages
English (en)
Inventor
G A Archer
L H Sternbach
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE386168B publication Critical patent/SE386168B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/74Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/74Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C07D239/76N-oxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
SE7008427A 1966-01-19 1967-01-19 Nya kinazolinderivat till anvendning som mellanprodukter for framstellning av terapeutisk verdefulla bensoiazepinderivat SE386168B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52155166A 1966-01-19 1966-01-19

Publications (1)

Publication Number Publication Date
SE386168B true SE386168B (sv) 1976-08-02

Family

ID=24077176

Family Applications (4)

Application Number Title Priority Date Filing Date
SE00810/67A SE335858B (sv) 1966-01-19 1967-01-19
SE02828/69A SE353717B (sv) 1966-01-19 1967-01-19
SE7008427A SE386168B (sv) 1966-01-19 1967-01-19 Nya kinazolinderivat till anvendning som mellanprodukter for framstellning av terapeutisk verdefulla bensoiazepinderivat
SE811/67A SE321233B (sv) 1966-01-19 1967-01-19

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE00810/67A SE335858B (sv) 1966-01-19 1967-01-19
SE02828/69A SE353717B (sv) 1966-01-19 1967-01-19

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE811/67A SE321233B (sv) 1966-01-19 1967-01-19

Country Status (16)

Country Link
US (1) US3446806A (sv)
JP (1) JPS4938814B1 (sv)
BE (2) BE692378A (sv)
CH (3) CH560692A5 (sv)
DE (2) DE1695176A1 (sv)
DK (4) DK114556B (sv)
ES (2) ES335788A1 (sv)
FI (1) FI47576C (sv)
FR (2) FR1507878A (sv)
GB (2) GB1144516A (sv)
GR (2) GR33806B (sv)
IL (2) IL27189A (sv)
MY (2) MY6900383A (sv)
NL (3) NL6700785A (sv)
OA (1) OA02391A (sv)
SE (4) SE335858B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310429A (en) * 1978-06-19 1982-01-12 The B. F. Goodrich Company Stabilized polymers, novel stabilizers, and synthesis thereof
US4601839A (en) * 1978-06-19 1986-07-22 The B. F. Goodrich Company Stabilized polymers, novel stabilizers, and synthesis thereof
US4472435A (en) * 1980-07-31 1984-09-18 Hoffman-La Roche Inc. Benzophenone derivatives useful in treating heart failure
WO1995024394A1 (en) * 1994-03-08 1995-09-14 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3267110A (en) * 1960-06-03 1966-08-16 Smith Kline French Lab Trifluoromethyl substituted o-aminophenyl ketones
US3321467A (en) * 1963-11-27 1967-05-23 Hoffmann La Roche 3-halo-1, 4-benzodiazepin-2-ones

Also Published As

Publication number Publication date
FI47576C (sv) 1974-01-10
BE692378A (sv) 1967-07-10
CH553193A (en) 1974-08-30
FR1508490A (fr) 1968-01-05
DK119656B (da) 1971-02-08
GB1144515A (en) 1969-03-05
SE353717B (sv) 1973-02-12
CH560692A5 (sv) 1975-04-15
FR1507878A (fr) 1967-12-29
US3446806A (en) 1969-05-27
DK120347B (da) 1971-05-17
GR33806B (el) 1968-02-06
DK120392B (da) 1971-05-24
SE321233B (sv) 1970-03-02
GR35752B (el) 1968-10-25
MY6900384A (en) 1969-12-31
SE335858B (sv) 1971-06-14
NL131198C (sv)
CH461517A (de) 1968-08-31
IL27189A (en) 1971-01-28
ES335789A1 (es) 1967-12-16
DE1618486A1 (de) 1971-04-01
BE692558A (sv) 1967-07-13
OA02391A (fr) 1970-05-05
DK114556B (da) 1969-07-14
NL6700785A (sv) 1967-07-20
GB1144516A (en) 1969-03-05
IL27212A (en) 1971-04-28
ES335788A1 (es) 1968-03-16
JPS4938814B1 (sv) 1974-10-21
MY6900383A (en) 1969-12-31
FI47576B (sv) 1973-10-01
NL6700786A (sv) 1967-07-20
DE1695176A1 (de) 1970-04-16

Similar Documents

Publication Publication Date Title
FI54301C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE431756B (sv) Fenoxi-2-oxopropylfosfonat till anvendning som mellanprodukt vid framstellning av nya w-pentanorprostaglandiner
SE386672B (sv) Mellanprodukter for framstellning av isokinolinderivat
SE387358B (sv) Vid rumstemperatur till elaster vulkbara massor samt butoxiacetoxikiselforeningar for framstellning av massorna
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE390634B (sv) Alfa-bensyliden-beta, beta-dialkoxipropiontriler till anvendning som mellanprodukter for framstellning av antibakteriellt verksamma 2,4-diamino-5-bensylpyrimidiner
FI55184C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma fenyl-2-pyrrolidinoner samt deras isomerer
SE382200B (sv) Forfarande for framstellning av veteperoxid
SE389671B (sv) Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan
SE401507B (sv) Nya trans-epoxi-cis-alkener avsedda som mellanprodukter for framstellning av prostaglandinderivat
SE392903B (sv) Foreningar till anvendning som mellanprodukter for framstellning av mjoldryga-peptidalkaloider
SE7511680L (sv) Forfarande for framstellning av furanderivat
FI54602C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 6-amidinopenicillansyraderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
FI54294B (fi) Foerfarande foer framstaellning av farmakologiskt verksamma isoindolinderivat
SE386168B (sv) Nya kinazolinderivat till anvendning som mellanprodukter for framstellning av terapeutisk verdefulla bensoiazepinderivat
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE7700287L (sv) Nya foreningar till anvendning som mellanprodukter vid framstellning av aminosubstituerade tetracykliska foreningar
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
FI53700C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara diaminopropiofenonderivat
SE397086B (sv) 3-cyancyklopentenonderivat till anvendning som utgangsmaterial for framstellning av 3-hydroxialkenylcyklopentan-1,4-diolderivat samt forfarande for framstellning av 3-cyancyklopentenonderivatet
SE386681B (sv) Forfarande for framstellning av nya cefalosporinderivat
SE383738B (sv) Forfarande for framstellning av sulfamoyl-bensensulfonamider med terapeutiska egenskaper